Pharmaceuticals in India
Summary
Pharmaceuticals in India industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
- The Indian pharmaceuticals market registered revenues of $48 billion in 2023, representing a compound annual growth rate (CAGR) of 7.7% between 2018 and 2023.
- The Indian pharmaceuticals market is characterized by the availability of low-cost and high-quality medicines, making it the “pharmacy of the world”.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in India
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in India
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the India pharmaceuticals market with five year forecasts
- What was the size of the India pharmaceuticals market by value in 2023?
- What will be the size of the India pharmaceuticals market in 2028?
- What factors are affecting the strength of competition in the India pharmaceuticals market?
- How has the market performed over the last five years?
- What are the main segments that make up India's pharmaceuticals market?
- 1 Executive Summary
- 1.1. Market value
- 1.2. Market value forecast
- 1.3. Geography segmentation
- 1.4. Market rivalry
- 1.5. Competitive landscape
- 2 Market Overview
- 2.1. Market definition
- 2.2. Market analysis
- 3 Market Data
- 3.1. Market value
- 4 Market Segmentation
- 4.1. Geography segmentation
- 5 Market Outlook
- 5.1. Market value forecast
- 6 Five Forces Analysis
- 6.1. Summary
- 6.2. Buyer power
- 6.3. Supplier power
- 6.4. New entrants
- 6.5. Threat of substitutes
- 6.6. Degree of rivalry
- 7 Competitive Landscape
- 7.1. Who are the leading players?
- 7.2. What strategies do leading players follow?
- 7.3. What are the strengths of the leading players?
- 7.4. What are the recent developments in the market?
- 8 Company Profiles
- 8.1. Sun Pharmaceutical Industries Ltd
- 8.2. Lupin Ltd
- 8.3. Cipla Ltd
- 8.4. Dr. Reddy's Laboratories Ltd
- 9 Macroeconomic Indicators
- 9.1. Country data
- 10 Appendix
- 10.1. Methodology
- 10.2. Industry associations
- 10.3. Related MarketLine research
- 10.4. About MarketLine
- List of Tables
- Table 1: India pharmaceuticals market value: $ billion, 2018-23
- Table 2: India pharmaceuticals market geography segmentation: $ billion, 2023
- Table 3: India pharmaceuticals market value forecast: $ billion, 2023-28
- Table 4: Sun Pharmaceutical Industries Ltd: Key Facts
- Table 5: Sun Pharmaceutical Industries Ltd: Annual Financial Ratios
- Table 6: Sun Pharmaceutical Industries Ltd: Key Employees
- Table 7: Lupin Ltd: Key Facts
- Table 8: Lupin Ltd: Annual Financial Ratios
- Table 9: Lupin Ltd: Key Employees
- Table 10: Lupin Ltd: Key Employees Continued
- Table 11: Cipla Ltd: Key Facts
- Table 12: Cipla Ltd: Annual Financial Ratios
- Table 13: Cipla Ltd: Key Employees
- Table 14: Dr. Reddy's Laboratories Ltd: Key Facts
- Table 15: Dr. Reddy's Laboratories Ltd: Annual Financial Ratios
- Table 16: Dr. Reddy's Laboratories Ltd: Key Employees
- Table 17: India Size of Population (million), 2018-23
- Table 18: India Real GDP (constant 2010 prices, $ billion), 2018-23
- Table 19: India GDP (current prices, $ billion), 2018-23
- Table 20: India Inflation, 2018-23
- Table 21: India Consumer Price Index (absolute), 2018-23
- Table 22: India Exchange Rate, 2018-23
- List of Figures
- Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook